Anteneh Yitayal S, Yang Qi, Brown Melissa H, Franco Christopher M M
College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia.
Department of Medical Microbiology, College of Medicine, Addis Ababa University, Addis Ababa 9086, Ethiopia.
Microorganisms. 2021 Jan 14;9(1):171. doi: 10.3390/microorganisms9010171.
The misuse and overuse of antibiotics have led to the emergence of multidrug-resistant microorganisms, which decreases the chance of treating those infected with existing antibiotics. This resistance calls for the search of new antimicrobials from prolific producers of novel natural products including marine sponges. Many of the novel active compounds reported from sponges have originated from their microbial symbionts. Therefore, this study aims to screen for bioactive metabolites from bacteria isolated from sponges. Twelve sponge samples were collected from South Australian marine environments and grown on seven isolation media under four incubation conditions; a total of 1234 bacterial isolates were obtained. Of these, 169 bacteria were tested in media optimized for production of antimicrobial metabolites and screened against eleven human pathogens. Seventy bacteria were found to be active against at least one test bacterial or fungal pathogen, while 37% of the tested bacteria showed activity against including methicillin-resistant strains and antifungal activity was produced by 21% the isolates. A potential novel active compound was purified possessing inhibitory activity against Using 16S rRNA, the strain was identified as sp. Our study highlights that the marine sponges of South Australia are a rich source of abundant and diverse bacteria producing metabolites with antimicrobial activities against human pathogenic bacteria and fungi.
抗生素的滥用和过度使用导致了多重耐药微生物的出现,这降低了用现有抗生素治疗感染者的几率。这种耐药性促使人们从包括海洋海绵在内的新型天然产物丰富生产者中寻找新的抗菌药物。许多从海绵中报道的新型活性化合物都源自其微生物共生体。因此,本研究旨在从海绵分离出的细菌中筛选生物活性代谢产物。从南澳大利亚海洋环境中采集了12个海绵样本,并在4种培养条件下在7种分离培养基上培养;共获得1234株细菌分离物。其中,169株细菌在优化用于生产抗菌代谢产物的培养基中进行测试,并针对11种人类病原体进行筛选。发现70株细菌对至少一种测试细菌或真菌病原体具有活性,而37%的测试细菌对包括耐甲氧西林菌株在内的 显示出活性,21%的分离物产生了抗真菌活性。纯化出一种对 具有抑制活性的潜在新型活性化合物。利用16S rRNA,该菌株被鉴定为 属。我们的研究强调,南澳大利亚的海洋海绵是丰富多样的细菌的丰富来源,这些细菌产生对人类病原菌和真菌具有抗菌活性的代谢产物。